INS and Insulin resistance: Two meta-analyses carried out consecutively in 2020 and 2022 showed that probiotics improve carbohydrate metabolism and insulin activity indicators, such as HOMA-IR and QUICKI, and can reduce the risk of insulin resistance in patients with GDM [53,61].